Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stromal cell-derived factor 2 (SDF2) is a conserved, ubiquitously expressed protein localized mainly in the endoplasmic reticulum (ER), where it functions as a regulatory cofactor involved in protein folding and the unfolded protein response (UPR)[1][2][3][4][5]. Unlike SDF1/CXCL12 and other stromal cell-derived factors, SDF2 is not a chemokine or receptor, but rather an ER-resident protein associated with protein folding and cellular stress adaptation[1][2][4]. SDF2 expression is altered in cancer, placental disorders, and other disease contexts linked to ER stress, making it a candidate biomarker for certain conditions but not a direct druggable target[2][4][5]. Critical notes: - SDF2 should not be confused with "SDF-1" (CXCL12), a chemokine/receptor widely targeted in drug discovery. - The name "stromal cell derived factor 2" is correct for this protein; however, its function is regulatory in ER homeostasis, *not as a receptor or chemokine*. - SDF2's therapeutic and biomarker potential is still being explored, especially for ER stress-related pathologies[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stromal cell-derived factor 2 (SDF2).